COMPANY PROFILE

Ablexis

Explore full profile

Biotechnology company developing an innovative, next-generation platform for antibody drug discovery

San Diego, United StatesFounded 2009Biotech & Life Sciences

Valuation $50–100M Last recorded · 2010

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Ablexis

Ablexis is a biotechnology company specializing in the development of a next-generation transgenic mouse platform designed for the discovery of therapeutic antibodies. The company's core product, the AlivaMab Mouse, is a transgenic mouse that significantly enhances the efficiency and effectiveness of antibody discovery compared to traditional methods. Ablexis primarily serves pharmaceutical companies, with a majority of the top 15 global pharmaceutical firms utilizing its platform for antibody drug discovery. The company operates in the biopharmaceutical market, focusing on licensing its proprietary technology to partners. Ablexis generates revenue through licensing agreements tailored to meet the specific needs of its clients, ensuring flexible and efficient collaboration.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2009
Headquarters: San Diego, United States
Employees: 1
Open positions: None listed
Dealroom signal: 26.0/100
Industry: Health, Enterprise Software
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model: Manufacturing, SaaS
Client focus: b2c
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

1 recorded event

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES A✓Equity / VC	Jun 2010	$12M	$48M	Third Rock Ventures	—

Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Ablexis website traffic

Latest recorded traffic for Ablexis is 2.3K monthly website visits, up 15% over the last three months. Ablexis's team grew 0% over the past year.

Latest monthly visits2.3K 3-month web change+15% 1-year team growth0%

Monthly website visitsApr 2016–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
MEMedpricer.comThe only complete cost management solution for healthcare organizations that integrates software and services for purchased services	Guilford, United States	Operational	3	—	—
NONootroboxEnhance your cognitive performance. #brainfood	San Francisco, United States	Operational
CHChronicledChronicled is a technology company leveraging blockchain and IoT to power smart, secure supply chain solutions	San Francisco, United States	Operational
HEHealthonomyData management tool for medical providers who treat patients covered under the california workers’ compensation program	Menlo Park, United States	Closed
ARArpeggiAnalysis and data management for medical industry	Austin, United States	Acquired
RARadialogicaHealthcare information technology company providing software solutions for radiation oncology and the healthcare market	St. Louis, United States	Operational
QUQualMetrixHealthcare analytics, insights and innovative reporting to payers, providers and employers	Miami, United States	Operational
RXRxDataRxData is developing a platform for international pharma pricing and access data	New York City, United States	Operational